Thirunavukkarasu Angappan: The Global Shift Toward Plasma Self-Sufficiency
Thirunavukkarasu Angappan, Vice President of Operations and Manufacturing at PopVax, shared a post on LinkedIn:
“Plasma Self-Sufficiency Just Became Corporate Strategy, Not Just Policy
For years, plasma self-sufficiency was mostly something governments talked about.
Over the last 18 months, it’s become something companies are actually building toward – and Grifols is the clearest example.
November 2025: Grifols bought a majority stake (50.1%) in a Canadian plasma-collection company, strengthening its control over plasma sourced in Canada.
December 2025, one month later: Grifols received EU (EMA) certification for its entire Egyptian plasma operation – a joint venture that turns local Egyptian plasma into medicines approved for sale across Europe.
This made Egypt the first country in Africa or the Middle East with this level of certification.
Later, in April 2026: Grifols closed 29 of its US donation centers, while also preparing to spin off and IPO a separate, self-sufficient US Biopharma business.
Context: Roughly 40% of Europe’s plasma supply has historically come from the United States.
Building EU-certified plasma capacity in Egypt and Canada isn’t just expansion – it’s a hedge against that US dependence, timed to a plasma market still growing at a high single-digit rate every year.
Will other major plasma companies follow Grifols toward building their own regional, self-sufficient supply chains – or does scale still favor staying consolidated around a few very large, centralized sourcing hubs?”

Stay updated with Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health